Actively Recruiting
Chronic Coronary Syndrome Snapshot Study Evaluating Adherence to 2019 ESC Guidelines and Barriers to Implementation
Led by European Society of Cardiology · Updated on 2025-01-09
4000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating how well healthcare professionals follow the 2019 European Society of Cardiology (ESC) Guidelines for managing Chronic Coronary Syndrome (CCS). This observational study aims to understand adherence levels across different healthcare settings and regions, as well as identify barriers and factors that help guideline implementation. It focuses on adults with suspected or confirmed CCS, including various patient categories such as those with angina, heart failure, or recent acute coronary events. The study involves enrolling adult patients receiving usual care for CCS without extra interventions beyond standard treatment. Participants come from diverse healthcare settings including hospitals, outpatient clinics, and primary care. The study includes two visits: an enrollment visit and a follow-up visit three months later. During this time, researchers collect information about how closely care follows the ESC guidelines across different patient groups and settings. Participants will be involved in assessments at enrollment and after three months to evaluate guideline adherence and explore regional and demographic differences. The study also seeks to identify barriers and facilitators affecting guideline use, including access to cardiovascular care among different sex and ethnic groups. The main outcome is the level of adherence to the ESC guidelines over the study period, monitored without additional treatments or procedures beyond usual care.
CONDITIONS
Brief Title
Chronic Coronary Syndrome Snapshot Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with angina and/or dyspnoea, and suspected coronary artery disease.
- Patients with new onset of heart failure or reduced left ventricular function.
- Patients within 1 year after an acute coronary syndrome or recent revascularisation.
- Patients beyond 1 year after initial diagnosis or revascularisation.
- Patients with Angina with No Obstructive Coronary Artery disease (ANOCA) such as microvascular angina or vasospastic angina.
- Asymptomatic subjects referred for screening for coronary artery disease.
You will not qualify if you...
- Patients with a recent acute coronary syndrome within 1 month.
- Patients with conditions unrelated to CCS that limit participation or interfere with assessment.
- Patients participating in any clinical study recommending deviations from guideline recommendations.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 months
Participants with confirmed or suspected Chronic Coronary Syndrome are observed to evaluate adherence to the 2019 ESC Guidelines and identify barriers to guideline implementation.
1 enrollment visit and 1 follow-up visit at 3 months
Trial Site Locations
Total: 1 location
1
Erebouni Medical Center
Yerevan, Armenia
Actively Recruiting
Research Team
E
Emilie Head of Department
C
Carole Clinical Project Manager
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here